SILO PHARMA INC (SILO) Stock Balance Sheet
NASDAQ:SILO - US82711P2011 - Common Stock
0.6105 USD
+0.01 (+1.63%)
0.6288 USD
+0.02 (+3%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.33M | 3.91M | 3.52M | 11.37M | 9.84M | |||
| Marketable Securities | 1.93M | 3.17M | 4.14M | 0.00 | 420.00K | |||
| Receivables | N/A | N/A | 0.00 | 70.00K | 0.00 | |||
| Inventories | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 113.10K | 31.00K | 16.00K | 140.00K | 150.00K | |||
| Total Current Assets | 6.37M | 7.11M | 7.68M | 11.57M | 10.40M | |||
| Non-Current Assets | ||||||||
| Intangibles | 223.30K | 241.20K | N/A | N/A | N/A | |||
| Other Non-Current Assets | 56.20K | 59.20K | 65.00K | 70.00K | 30.00K | |||
| Total Non-Current Assets | 279.50K | 300.30K | 64.90K | 70.00K | 90.00K | |||
| TOTAL ASSETS | 6.65M | 7.41M | 7.75M | 11.64M | 10.49M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accounts Payable | 977.80K | 1.58M | 703.50K | 360.00K | 420.00K | |||
| Other Current Liabilities | 72.10K | 72.10K | 72.10K | 70.00K | 70.00K | |||
| Total Current Liabilities | 1.05M | 1.66M | 775.60K | 440.00K | 490.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 685.50K | 721.60K | 793.70K | 870.00K | 940.00K | |||
| Total Non-Current Liabilities | 685.50K | 721.60K | 793.70K | 860.00K | 940.00K | |||
| TOTAL LIABILITIES | 1.74M | 2.38M | 1.57M | 1.30M | 1.43M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -17.50M | -15.26M | -10.87M | -7.17M | -3.26M | |||
| Additional Paid In Capital | 22.41M | 20.30M | 17.53M | 17.51M | 12.31M | |||
| Common Shares | 900.00 | 500.00 | 300.00 | 0.00 | 10.00K | |||
| Treasury Stock | N/A | N/A | -471.10K | N/A | N/A | |||
| Other Shareholders' Equity | 9.60K | 2.40K | -6.20K | N/A | N/A | |||
| Shares Outstanding | 8.65M | 4.48M | 2.91M | 3.16M | 1.97M | |||
| Tangible Book Value per Share | 0.54 | 1.07 | 2.13 | 3.27 | 4.60 | |||
| Total Shareholders' Equity | 4.92M | 5.03M | 6.18M | 10.34M | 9.06M | |||
| TOTAL LIABILITIES AND EQUITY | 6.65M | 7.41M | 7.75M | 11.64M | 10.49M | |||
| Statistics | ||||||||
| Current Ratio | 6.07 | 4.29 | 9.90 | 26.30 | 21.22 | |||
| Return On Assets (ROA) | -73.58% | -59.27% | -47.78% | -33.59% | 23.83% | |||
| Return On Equity (ROE) | -99.55% | -87.26% | -59.91% | -37.81% | 27.59% | |||
All data in USD , ROIC based on taxRate of 0.21